Loading
Latest filing published 17 Sept 2026 for Beta Bionics, Inc., €51k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mike Mensinger discloses dealings in Beta Bionics, Inc. to SEC (Form 4). The record holds 11 filings, for trades running from 31 January 2025 to 16 September 2026.
Every open-market trade on record is a sale: 8 sales worth €457k. The rest of the record consists of 2 share grants. Since January 2026: no purchases and 5 sales on the market.
The newest entry dates from 17 September 2026: an open-market sale of €51k, in Beta Bionics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 of 11 declarations